PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.02%
Revenue growth under 50% of NXPI's 4.09%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-3.26%
Negative gross profit growth while NXPI is at 4.47%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3.40%
Negative EBIT growth while NXPI is at 5.87%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.06%
Negative operating income growth while NXPI is at 5.87%. Joel Greenblatt would press for urgent turnaround measures.
-0.75%
Negative net income growth while NXPI stands at 12.75%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-0.53%
Negative EPS growth while NXPI is at 13.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-1.07%
Negative diluted EPS growth while NXPI is at 12.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.09%
Maintaining or increasing dividends while NXPI cut them. John Neff might see a strong edge in shareholder returns.
38.46%
OCF growth 1.25-1.5x NXPI's 30.69%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
1040.43%
FCF growth above 1.5x NXPI's 48.02%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.63%
10Y revenue/share CAGR under 50% of NXPI's 165.66%. Michael Burry would suspect a lasting competitive disadvantage.
13.51%
5Y revenue/share CAGR under 50% of NXPI's 75.93%. Michael Burry would suspect a significant competitive gap or product weakness.
19.91%
3Y revenue/share CAGR under 50% of NXPI's 61.78%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
103.13%
10Y OCF/share CAGR under 50% of NXPI's 220.35%. Michael Burry would worry about a persistent underperformance in cash creation.
-1.85%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
35.56%
3Y OCF/share CAGR under 50% of NXPI's 100.23%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
227.96%
Net income/share CAGR at 50-75% of NXPI's 390.60%. Martin Whitman might question if the firm’s product or cost base lags behind.
16.17%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
27.56%
Below 50% of NXPI's 3920.57%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
81.65%
Below 50% of NXPI's 582.31%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
68.77%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
101.75%
3Y equity/share CAGR above 1.5x NXPI's 2.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
341.28%
Dividend/share CAGR of 341.28% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.61%
Dividend/share CAGR of 99.61% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.84%
Below 50% of NXPI's 168.07%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
1.02%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.80%
Inventory growth well above NXPI's 1.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.26%
Asset growth above 1.5x NXPI's 0.84%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.34%
Similar to NXPI's 4.46%. Walter Schloss finds parallel capital usage or profit distribution strategies.
0.03%
Debt growth far above NXPI's 0.02%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-1.26%
Our R&D shrinks while NXPI invests at 2.04%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.95%
We cut SG&A while NXPI invests at 7.30%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.